← All candidates
Three insiders bought $50.4K in two days.
14 filings on record.
CTSOCytosorbents Corp
NasdaqCM · Healthcare · $18.06M
$5.73
-5.45% · Sep 16
Three insiders bought $50.4K in two days.
Led by Chan Phillip P., chief executive officer.
Price · 1Y · daily● 9 buys◆ 4 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 2×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what CTSO ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$18.06M
Float
2.7M
86% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
0.5
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Chief Executive Officer
Chan Phillip P.
Bought $100.5K on Jun 12 — 251,136 sh @ $0.4000, held direct, 15% of their stake.
No completed positions to measure
Chief Financial Officer
Mariani Peter J
Bought $44.0K on Jun 15 — 100,000 sh @ $0.4400, held direct, 16% of their stake.
No completed positions to measure
Director
Sobel Alan D.
Bought $11.6K on Sep 15 — 1,900 sh @ $6.12, held direct, 21% of their stake.
No completed positions to measure
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
9 more transactions on Pro →Context
Wall St
$2.88 avg target
-49.8% vs today · 2 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 4 quarters beat
Q1 '26−$0.08 act−$0.03
Q4 '25−$0.09 act−$0.04
Q3 '25−$0.05 act−$0.00
Q2 '25$0.03 act+$0.09
Coverage
CytoSorbents Corp (CTSO) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...GuruFocus.com · 05-14Transcript: CytoSorbents Q1 2026 Earnings Conference CallBenzinga · 05-13Cytosorbents (CTSO) Q4 2025 Earnings TranscriptMotley Fool · 03-26Cytosorbents Corporation Q4 2025 Earnings Call SummaryMoby · 03-26
The file stays open
14 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice